How a family’s quest to save their children from a deadly disease, launched a biotech company.

Summary: At Amicus Therapeutics, it’s not just business – it’s personal. CEO John Crowley founded the New Jersey-based biotech company in 2002, to save his two children from a rare and often deadly disease. Crowley sits down with Yahoo Finance’s Alexis Christoforous to share his family’s story, the strides Amicus has made in the rare disease space and the company’s new $100 million bet on gene therapy.  <br><hr><p style="color: grey;">See <a style="color: grey;" target="_blank" rel="noopener noreferrer" href="https://acast.com/privacy">acast.com/privacy</a> for privacy and opt-out information.</p>